Information was received from a healthcare provider (hcp) via a manufacturer representative (rep) regarding a patient who was implanted with an implantable neurostimulator (ins) for non-malignant pain and failed back surgery syndrome.It was reported that the patient had signs of infection of their surgical wound.It was reported that the patient fell one month post-op (date unknown), dehiscing/splitting open the wound at the battery site.It was reported that the incision drained serosanguinous fluid.No troubleshooting was done related to the stimulator.Cultures were taken and preliminarily showed a staph infection.The patient was placed on oral antibiotics, but after no improvements were seen in reducing the infectious drainage, the patient's doctor elected to irrigate the wound in a surgical setting.Actions taken to address the issue was a surgical incision, drainage, antibiotics were placed in the wound and the patient was placed on oral antibiotics.It was unknown if the issue was resolved the rep indicated that they would follow-up for more information.It was reported that the rep would be present at the follow-up appointment on (b)(6) 2021 and would provide a further update at that time unless the patient's condition changes prior to this assessment.
|